Trials / Unknown
UnknownNCT04933357
Multimodality- Adapted Dose Modification in Head and Neck Cancer Radiation Therapy 
Multimodality- Adapted Dose Modification in Head and Neck Cancer Radiation Therapy Using Functional Imaging
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- Sponsor
- National Cancer Institute, Egypt · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective trial evaluating dose escalation using an SBRT boost to poor- responding tumors by interim functional imaging (PET/CT and fMRI) to improve the local control of HNCSCC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Dose escalation | Dose escalation to poor responders to achieve dose equivalent more than 80 Gy using SBRT boost |
| RADIATION | Standard dose | Standard dose to good responders to achieve dose equivalent of 70 Gy. |
Timeline
- Start date
- 2019-09-16
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
- First posted
- 2021-06-21
- Last updated
- 2021-06-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04933357. Inclusion in this directory is not an endorsement.